A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease
Clinical trial NCT00665223 · COMPLETED
Trial details
- NCT number
- NCT00665223
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-24
- Primary completion
- 2010-06-14
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.